Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.
Conrado DJ, Larkindale J, Berg A, Hill M, Burton J, Abrams KR, Abresch RT, Bronson A, Chapman D, Crowther M, Duong T, Gordish-Dressman H, Harnisch L, Henricson E, Kim S, McDonald CM, Schmidt S, Vong C, Wang X, Wong BL, Yong F, Romero K; Duchenne Muscular Dystrophy Regulatory Science Consortium (D-RSC). Conrado DJ, et al. Among authors: vong c. J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):441-455. doi: 10.1007/s10928-019-09642-7. Epub 2019 May 24. J Pharmacokinet Pharmacodyn. 2019. PMID: 31127458
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy.
Lingineni K, Aggarwal V, Morales JF, Conrado DJ, Corey D, Vong C, Burton J, Larkindale J, Romero K, Schmidt S, Kim S; Cooperative International Neuromuscular Research Group investigators and Duchenne Regulatory Science Consortium members. Lingineni K, et al. Among authors: vong c. CPT Pharmacometrics Syst Pharmacol. 2022 Mar;11(3):318-332. doi: 10.1002/psp4.12753. Epub 2022 Jan 3. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 34877803 Free PMC article.
Estimands-What they are and why they are important for pharmacometricians.
Akacha M, Bartels C, Bornkamp B, Bretz F, Coello N, Dumortier T, Looby M, Sander O, Schmidli H, Steimer JL, Vong C. Akacha M, et al. Among authors: vong c. CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):279-282. doi: 10.1002/psp4.12617. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33951755 Free PMC article. No abstract available.
Comparisons of Analysis Methods for Proof-of-Concept Trials.
Karlsson KE, Vong C, Bergstrand M, Jonsson EN, Karlsson MO. Karlsson KE, et al. Among authors: vong c. CPT Pharmacometrics Syst Pharmacol. 2013 Jan 16;2(1):e23. doi: 10.1038/psp.2012.24. CPT Pharmacometrics Syst Pharmacol. 2013. PMID: 23887593 Free PMC article.
Role of autophagy in myocardial remodeling after myocardial infarction.
Tian RZ, Zhuang DL, Vong CT, He X, Ouyang Q, Liang JH, Guo YP, Wang YH, Zhao S, Yuan H, Nasser MI, Li G, Zhu P. Tian RZ, et al. Among authors: vong ct. J Cardiovasc Pharmacol. 2024 Oct 25. doi: 10.1097/FJC.0000000000001646. Online ahead of print. J Cardiovasc Pharmacol. 2024. PMID: 39454200
111 results